FY 2025
|
Chart |
FY21
Dec 31, 2021
|
FY22
Dec 31, 2022
|
FY23
Dec 31, 2023
|
FY24
Dec 31, 2024
|
FY25
Dec 31, 2025
|
TTM
Trailing 12M
|
|---|---|---|---|---|---|---|---|
|
Revenue
Total sales generated. |
|
$17.59 B | $18.34 B | $19.55 B | $19.67 B | $20.63 B | $20.24 B |
|
Cost of Revenue Direct cost of goods/services. |
|
$10.41 B | $11.16 B | $11.63 B | $11.47 B | $12.38 B | $11.56 B |
Gross Profit Revenue minus cost of revenue. |
|
$7.17 B | $7.18 B | $7.92 B | $8.21 B | $8.25 B | $8.69 B |
|
Operating Expense
Costs to run business. 
|
|
$4.38 B | $4.66 B | $5.49 B | $5.58 B | $5.49 B | $6.12 B |
Operating Income Profit from operations. |
|
$2.80 B | $2.52 B | $2.44 B | $2.63 B | $2.76 B | $2.57 B |
|
Net Interest Income
Interest income minus expense.
|
|
-$6.00 M | -$86.00 M | -$516.00 M | -$505.00 M | -$450.00 M | -$442.00 M |
Non-Operating Income (ex-Int) Income outside core operations. |
|
-$120.00 M | -$10.00 M | -$468.00 M | -$461.00 M | -$445.00 M | $105.00 M |
Total Other Income (Net) Net non-operating items. |
|
$80.00 M | -$10.00 M | -$74.00 M | -$44.00 M | $6.00 M | -$528.00 M |
Income Before Tax Profit before taxes. |
|
$2.88 B | $2.51 B | $2.36 B | $2.58 B | $2.77 B | $2.04 B |
Income Tax Expense Taxes on income. |
|
$600.00 M | $563.00 M | $743.00 M | $531.00 M | $614.00 M | $446.00 M |
|
Net Income
Final profit.
|
|
$2.25 B | $1.92 B | $1.57 B | $1.99 B | $2.08 B | $1.59 B |
|
Earnings Per Share
Company profit allocated to each outstanding share. |
|||||||
EPS Earnings per share. Formula: Net Income ÷ Shares |
|
$4.90 | $4.22 | $3.04 | $4.37 | $3.68 | $3.48 |
Diluted EPS EPS including dilution. Formula: Net Income ÷ Diluted Shares |
|
$4.90 | $4.22 | $3.02 | $4.34 | $3.65 | $3.45 |
|
Shares for EPS
Number of shares used to calculate EPS. |
|||||||
Weighted Average Shares Outst. Avg shares used for EPS. |
|
454.71 M | 453.93 M | 455.00 M | 456.00 M | 456.52 M | 453.00 M |
Diluted Average Shares Outst. Shares including dilution. |
|
454.71 M | 453.93 M | 458.00 M | 459.00 M | 460.27 M | 454.00 M |
| Supplemental Items | |||||||
EBIT Earnings before interest and tax. |
|
$2.92 B | $2.53 B | $2.90 B | $3.09 B | $3.21 B | $2.47 B |
EBITDA Earnings before interest, tax, D&A. |
|
$3.54 B | $3.17 B | $3.51 B | $3.67 B | $3.79 B | $3.48 B |
Depreciation and Amortization Non-cash expense for assets. |
|
$625.00 M | $633.00 M | $610.00 M | $580.00 M | $578.00 M | $1.01 B |
| Company Report |
|
Sources
FY 2025
|
Sources
GE HealthCare Technologies's Balance Sheet
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading balance sheet when needed... |
|
Sources
GE HealthCare Technologies's Cash flow
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading cash flow statement when needed... |
|
Sources
GE HealthCare Technologies's Profitability
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading profitability metrics when needed... |
|
Sources
GE HealthCare Technologies's Ratios
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
|
Sources
